Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer

The prognosis of patients with Borrmann type IV gastric cancer (Type IV) is extremely poor. Thus, there is an urgent need to elucidate the molecular mechanisms underlying the oncogenesis of Type IV and to identify new therapeutic targets. Although previous studies using whole‐exome and whole‐genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasumoto, Makiko, Sakamoto, Etsuko, Ogasawara, Sachiko, Isobe, Taro, Kizaki, Junya, Sumi, Akiko, Kusano, Hironori, Akiba, Jun, Torimura, Takuji, Akagi, Yoshito, Itadani, Hiraku, Kobayashi, Tsutomu, Hasako, Shinichi, Kumazaki, Masafumi, Mizuarai, Shinji, Oie, Shinji, Yano, Hirohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269692/
https://www.ncbi.nlm.nih.gov/pubmed/27891760
http://dx.doi.org/10.1002/cam4.959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269692/
https://www.ncbi.nlm.nih.gov/pubmed/27891760
http://dx.doi.org/10.1002/cam4.959

Ejemplares similares